Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>Citi: CN 15th 5-Yr Plan in Line; Tech/ Tourism/ Healthcare Sectors Expected to Benefit
Recommend 25 Positive 29 Negative 13 |
||||
|
||||
|
China's 15th Five-Year Plan has been approved, with the top three core objectives being building a modern economic system, accelerating technological self-reliance, and establishing a strong domestic market, consistent with the top three goals of the 14th Five-Year Plan, according to a Citi research report. Likely due to increased overseas tariff barriers, it is worth noting that the goal of advancing high-level opening-up has made a big jump from 9th to 5th place. Overall, Citi considers the 15th Five-Year Plan within expectations, as it focuses on the five major directions the broker previously proposed, namely economic development, technological innovation, social welfare, green development, and reform and opening-up. The key sectors expected to benefit are technology, tourism, healthcare, insurance, and renewable energy. Citi holds a positive view on the Hong Kong and Chinese markets. Its top H-share buy recommendations are HENGRUI PHARMA (01276.HK), SUNNY OPTICAL (02382.HK), ASMPT (00522.HK), TENCENT (00700.HK), AIA (01299.HK), TRIP.COM-S (09961.HK), and Atour Lifestyle (ATAT.US). AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
